
Drew Moghanaki/LinkedIn
Aug 17, 2025, 11:55
Drew Moghanaki: SBRT for stage I NSCLC – When Guidelines and Experience Diverge
Drew Moghanaki, Chief Medical Officer at Respirati, shared a post on X:
“I learned today that the language in the NCCN guidelines defining who should get SBRT for stage I NSCLC is not broadly appreciated by pulmonologists who feel more than qualified to determine when a patient is high surgical risk.”
More posts featuring Drew Moghanaki.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 17, 2025, 11:40
Aug 17, 2025, 11:23
Aug 17, 2025, 11:10
Aug 17, 2025, 10:43
Aug 17, 2025, 10:22